C

토모큐브

475960KOSDAQ사진장비 및 광학기기 제조업

54.0 / 100

Reference Date: 2026-04-13

Financial Score21.5 / 40
News Sentiment12.5 / 25
Momentum10.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but PBR raises overvaluation concerns. Declined 5.7% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Tomocube develops advanced cell imaging equipment, such as HT-2H and HT-X1, based on Holotomography (HT) technology, revolutionizing biomedical research and diagnostics. Widely adopted by over 200 institutions across 50+ countries, including MIT and ETH Zurich, the company is expanding into industrial applications, enhancing growth potential through semiconductor and display measurement devices.

Number of Employees

76people

Average Salary

55.2M KRW

Score Calculation Basis

Detailed Financial Score

PER
Industry Average 21.874.0Point
PBR
17.77Industry Average 2.800.0Point

6.3x industry avg (risky)

ROE
-11.91Industry Average -11.913.5Point

In line with industry avg

Debt Ratio
3.03Industry Average 18.098.0Point

Half of industry avg (excellent)

Trend 2024~20256.0 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲90.4% (1-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲36.6% (1-year basis)

ROE Trend
0.0 / 4

Avg ROE -19.9% (improving, 2yr)

Detailed News Sentiment

2 totalPositive 0Neutral 1Negative 0Average Sentiment Score 50

Detailed Momentum

52-week position6.0Point

52w upper range (70%)

Current 51,500Won52-week high 66,30052-week low 16,320
1-month return2.0Point

1m -5.68% (slight drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

6 totalPositive 0Neutral 6Negative 0
  • Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-30
  • Neutral주식매수선택권부여에관한신고2026-03-30
  • Neutral정기주주총회결과2026-03-30
  • Neutral기업설명회(IR)개최2026-03-25
  • Neutral사업보고서 (2025.12)2026-03-20